Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review

References

• Nakano S Ito T Furuya K Ambulatory blood pressure level rather than dipper/nondipper status predicts vascular events in type 2 diabetic subjects Hypertens Res 2004 27 9 647 656 15750258
   PubMed Web of Science ®Google Scholar
• Salman RA Al-Rubeaan KA Incidence and risk factors of hypertension among Saudi type 2 diabetes adult patients: an 11-year prospective randomized study J Diabetes Complications 2009 23 2 95 101 18413199
   PubMed Web of Science ®Google Scholar
• Stratton IM Cull CA Adler AI Matthews DR Neil HA Holman RR Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) Diabetologia 2006 49 8 1761 1769 16736131
   PubMed Web of Science ®Google Scholar
• Anderson RJ Bahn GD Moritz TE VADT Study Group Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial Diabetes Care 2011 34 1 34 38 21059830
   PubMed Web of Science ®Google Scholar
• Gaede P Lund-Andersen H Parving HH Pedersen O Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 2008 358 6 580 591 18256393
   PubMed Web of Science ®Google Scholar
• Bakris GL Weir MR Shanifar S RENAAL Study Group Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study Arch Intern Med 2003 163 13 1555 1565 12860578
   PubMed Web of Science ®Google Scholar
• Hanefeld M Koehler C Gallo S Benke I Ott P Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study Cardiovasc Diabetol 2007 6 13 17462080
   PubMed Web of Science ®Google Scholar
• Eeg-Olofsson K Cederholm J Nilsson PM Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients Diabetologia 2009 52 1 65 73 18985314
   PubMed Web of Science ®Google Scholar
• Song SH Hardisty CA Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity QJM 2008 101 11 875 879 18776208
   PubMed Web of Science ®Google Scholar
• Mulnier HE Seaman HE Raleigh VS Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database Diabetologia 2006 49 12 2859 2865 17072582
   PubMed Web of Science ®Google Scholar
• Kim SK Kim HJ Ahn CW Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients Endocr J 2008 55 6 1085 1092 18724043
   PubMed Web of Science ®Google Scholar
• Scott R O’Brien R Fulcher G Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Diabetes Care 2009 32 3 493 498 18984774
   PubMed Web of Science ®Google Scholar
• Tseng CH Chong CK Tseng CP Shau WY Tai TY Hypertension is the most important component of metabolic syndrome in the association with ischemic heart disease in Taiwanese type 2 diabetic patients Circ J 2008 72 9 1419 1424 18724015
   PubMed Web of Science ®Google Scholar
• Kannel WB McGee DL Diabetes and cardiovascular risk factors: the Framingham study Circulation 1979 59 1 8 13 758126
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) Cardiovascular diseases (CVDs) [web page on the Internet] Fact sheet no 317 Geneva WHO 2012 [updated September]. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/index.html Accessed January 23, 2013
   Google Scholar
• Yusuf S Reddy S Ounpuu S Anand S Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation 2001 104 22 2746 2753 11723030
   PubMed Web of Science ®Google Scholar
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 1998 317 7160 703 713 9732337
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Standards of medical care in diabetes – 2013 Diabetes Care 2013 36 Suppl 1 S11 S66 23264422
   PubMed Web of Science ®Google Scholar
• WHO World Health Statistics 2012 Geneva WHO 2012 Available from: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf Accessed January 23, 2013
   Google Scholar
• Inzucchi SE Bergenstal RM Buse JB American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 2012 35 6 1364 1379 22517736
   PubMed Web of Science ®Google Scholar
  Erratum in: Diabetes Care 2013 36 2 490
   Web of Science ®Google Scholar
• Health and Environment Alliance (HEAL) Figures on Obesity and Diabetes in the European Union Brussels HEAL nd. Available from: http://www.env-health.org/IMG/pdf/Obesity_and_diabetes_in_the_European_Union_to_partners_2_.pdf Accessed February 14, 2013
   Google Scholar
• Romero CX Romero TE Shlay JC Ogden LG Dabelea D Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults Adv Prev Med 2012 2012 172423 23243516
   PubMedGoogle Scholar
• Cook-Huynh M Ansong D Steckelberg RC Prevalence of hypertension and diabetes mellitus in adults from a rural community in Ghana Ethn Dis 2012 22 3 347 352 22870580
   PubMed Web of Science ®Google Scholar
• Ford ES Mokdad AH Giles WH Galuska DA Serdula MK Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviors Obes Res 2005 13 1 118 122 15761170
   PubMedGoogle Scholar
• Shen J Goyal A Sperling L The emerging epidemic of obesity, diabetes, and the metabolic syndrome in China Cardiol Res Pract 2012 2012 178675 21961074
   PubMedGoogle Scholar
• Keenan NL Rosendorf KA Centers for Disease Control and Prevention (CDC) Prevalence of hypertension and controlled hypertension – United States, 2005–2008 MMWR Surveill Summ 2011 60 Suppl 94 97 21430632
   PubMedGoogle Scholar
• CDC Prevalence of overweight and obesity among adults with diagnosed diabetes – United States, 1988–1994 and 1999–2002 MMWR Morb Mortal Wkly Rep 2004 53 45 1066 1068 15549021
   PubMedGoogle Scholar
• Tiptaradol S Aekplakorn W Prevalence, awareness, treatment and control of coexistence of diabetes and hypertension in thai population Int J Hypertens 2012 2012 386453 22888406
   PubMedGoogle Scholar
• Thomas MC Atkins R Assessment and management of hypertension in patients with type 2 diabetes Intern Med J 2009 39 3 143 149 18771428
   PubMed Web of Science ®Google Scholar
• Chen XY Thomas GN Chen YK Chan JC Wong KS Atherosclerotic vascular disease rather than metabolic syndrome predicts ischemic stroke in diabetic patients Cerebrovasc Dis 2010 30 4 374 379 20693792
   PubMed Web of Science ®Google Scholar
• Kabakov E Norymberg C Osher E Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors J Cardiometab Syndr 2006 1 2 95 101 17679829
   PubMedGoogle Scholar
• Koehler C Ott P Benke I Hanefeld M DIG Study Group Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study Horm Metab Res 2007 39 9 632 635 17846969
   PubMed Web of Science ®Google Scholar
• Lu B Yang Y Song X An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus Metabolism 2006 55 8 1088 1096 16839846
   PubMed Web of Science ®Google Scholar
• Marchesini G Forlani G Cerrelli F WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes Diabet Med 2004 21 4 383 387 15049944
   PubMed Web of Science ®Google Scholar
• Relimpio F Martinez-Brocca MA Leal-Cerro A Variability in the presence of the metabolic syndrome in Type 2 diabetic patients attending a diabetes clinic. Influences of age and gender Diabetes Res Clin Pract 2004 65 2 135 142 15223225
   PubMed Web of Science ®Google Scholar
• Viswanathan V Snehalatha C Kumutha R Nair BM Ramachandran A Impact of Joint National Committee VII recommendations on diabetic microvascular complications J Assoc Physicians India 2004 52 873 876 15906837
   PubMedGoogle Scholar
• Makuyana D Gomo Z Munyombwe T Matenga JA Hakim JG Metabolic syndrome disorders in urban black Zimbabweans with type 2 Diabetes mellitus Cent Afr J Med 2004 50 3–4 24 29 15490713
   PubMedGoogle Scholar
• Choukem SP Kengne AP Dehayem YM Simo NL Mbanya JC Hypertension in people with diabetes in sub-Saharan Africa: revealing the hidden face of the iceberg Diabetes Res Clin Pract 2007 77 2 293 299 17184871
   PubMed Web of Science ®Google Scholar
• Alebiosu CO Odusan BO Metabolic syndrome in subjects with type-2 diabetes mellitus J Natl Med Assoc 2004 96 6 817 821 15233492
   PubMed Web of Science ®Google Scholar
• Puepet FH Agaba EI Chuhwak EK Some metabolic abnormalities in type 2 diabetic patients in Jos, north central Nigeria Niger J Med 2003 12 4 193 197 14768192
   PubMedGoogle Scholar
• Ogbera AO Azenabor AO Hyperuricaemia and the metabolic syndrome in type 2 DM Diabetol Metab Syndr 2010 2 24 20406485
   PubMed Web of Science ®Google Scholar
• Ikem RT Akinola NO Balogun MO Ohwovoriole AE Akinsola A What does the presence of hypertension portend in the Nigerian with non insulin dependent diabetes mellitus West Afr J Med 2001 20 2 127 130 11768011
   PubMedGoogle Scholar
• Isezuo SA Ezunu E Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients J Natl Med Assoc 2005 97 4 557 563 15868776
   PubMed Web of Science ®Google Scholar
• Bunnag P Plengvidhya N Deerochanawong C Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes J Med Assoc Thai 2006 89 Suppl 1 S72 S77 17715837
   PubMedGoogle Scholar
• El-Hazmi MA Warsy AS Association of hypertension and non-insulin-dependent diabetes mellitus in the Saudi population Ann Saudi Med 2001 21 1–2 5 8 17264579
   PubMed Web of Science ®Google Scholar
• Alwakeel JS Sulimani R Al-Asaad H Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia Ann Saudi Med 2008 28 4 260 266 18596402
   PubMed Web of Science ®Google Scholar
• Kim WY Kim JE Choi YJ Huh KB Nutritional risk and metabolic syndrome in Korean type 2 diabetes mellitus Asia Pac J Clin Nutr 2008 17 Suppl 1 47 51 18296299
   PubMed Web of Science ®Google Scholar
• Mubarak FM Froelicher ES Jaddou HY Ajlouni KM Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan Ann Saudi Med 2008 28 5 346 351 18779643
   PubMed Web of Science ®Google Scholar
• Chan GC Type 2 diabetes mellitus with hypertension at primary healthcare level in Malaysia: are they managed according to guidelines? Singapore Med J 2005 46 3 127 131 15735877
   PubMedGoogle Scholar
• Khuwaja AK Rafique G White F Azam SI Macrovascular complications and their associated factors among persons with type 2 diabetes in Karachi, Pakistan – a multi-center study J Pak Med Assoc 2004 54 2 60 66 15134205
   PubMedGoogle Scholar
• Shera AS Jawad F Maqsood A Jamal S Azfar M Ahmed U Prevalence of chronic complications and associated factors in type 2 diabetes J Pak Med Assoc 2004 54 2 54 59 15134204
   PubMedGoogle Scholar
• Tariq M Hadi A Rahman SU Metabolic syndrome in type-2 diabetics: an update on the silent epidemic Rawal Medical Journal 2010 35 2 201 204
   Google Scholar
• Tzeng TF Hsiao PJ Hsieh MC Shin SJ Association of nephropathy and retinopathy, blood pressure, age in newly diagnosed type 2 diabetes mellitus Kaohsiung J Med Sci 2001 17 6 294 301 11559967
   PubMedGoogle Scholar
• Tseng CH Body mass index and blood pressure in adult type 2 diabetic patients in Taiwan Circ J 2007 71 11 1749 1754 17965496
   PubMed Web of Science ®Google Scholar
• Janghorbani M Amini M Metabolic syndrome in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors Metab Syndr Relat Disord 2007 5 3 243 254 18370778
   PubMedGoogle Scholar
• Vikram NK Misra A Pandey RM Anthropometry and body composition in northern Asian Indian patients with type 2 diabetes: receiver operating characteristics (ROC) curve analysis of body mass index with percentage body fat as standard Diabetes Nutr Metab 2003 16 1 32 40 12848303
   PubMedGoogle Scholar
• Dhobi GN Majid A Masoodi SR Bashir MI Wani AI Zargar AH Prevalence of hypertension in patients with new onset type 2 diabetes mellitus J Indian Med Assoc 2008 106 2 92 94 98 18705251
   PubMedGoogle Scholar
• Tharkar S Satyavani K Viswanathan V Cost of medical care among type 2 diabetic patients with a co-morbid condition – hypertension in India Diabetes Res Clin Pract 2009 83 2 263 267 19118912
   PubMed Web of Science ®Google Scholar
• Hassing LB Hofer SM Nilsson SE Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study Age Ageing 2004 33 4 355 361 15136287
   PubMed Web of Science ®Google Scholar
• Torffvit O Tencer J Rippe B The response to antihypertensive therapy is dependent on renal structural changes. A 5-year prospective study of renal biopsy in type 2 diabetic patients with micro-macroalbuminuria J Diabetes Complications 2010 24 6 361 367 20097099
   PubMed Web of Science ®Google Scholar
• Nilsson PM Cederholm J Zethelius BR Eliasson BR Eeg-Olofsson K Gudbj Rnsdottir S Trends in blood pressure control in patients with type 2 diabetes: data from the Swedish National Diabetes Register (NDR) Blood Press 2011 20 6 348 354 21675827
   PubMed Web of Science ®Google Scholar
• Skliros E Sotiropoulos A Vasibossis A Poor hypertension control in Greek patients with diabetes in rural areas. The VANK study in primary care Rural Remote Health 2007 7 3 583 17617008
   PubMedGoogle Scholar
• Comaschi M Coscelli C Cucinotta D Malini P Manzato E Nicolucci A SFIDA Study Group – Italian Association of Diabetologists (AMD) Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study Nutr Metab Cardiovasc Dis 2005 15 3 204 211 15955469
   PubMed Web of Science ®Google Scholar
• Bacci S Rizza S Prudente S The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients Diabetes 2011 60 3 1000 1007 21282363
   PubMed Web of Science ®Google Scholar
• Zoppini G Verlato G Leuzinger C Body mass index and the risk of mortality in type II diabetic patients from Verona Int J Obes Relat Metab Disord 2003 27 2 281 285 12587011
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB Sargeant LA Prevost AT How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes? Diabet Med 2008 25 12 1433 1439 19046242
   PubMed Web of Science ®Google Scholar
• Higgins GT Khan J Pearce IA Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies? Acta Ophthalmol Scand 2007 85 7 772 776 17944626
   PubMedGoogle Scholar
• Song SH Hardisty CA Early onset type 2 diabetes mellitus: a harbinger for complications in later years – clinical observation from a secondary care cohort QJM 2009 102 11 799 806 19734298
   PubMed Web of Science ®Google Scholar
• Dehout F Haumont S Gaham N Amoussou-Guenou K Hermans MP Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: prevalence, gender differences and HOMA hyperbolic product Diabetes Metab Syndr Clin Res Rev 2008 2 1 5 11
   Google Scholar
• Hu G Sarti C Jousilahti P The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality Stroke 2005 36 12 2538 2543 16282538
   PubMed Web of Science ®Google Scholar
• Hu G Jousilahti P Tuomilehto J Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease Eur Heart J 2007 28 24 3059 3066 17981826
   PubMed Web of Science ®Google Scholar
• Bosevski M Pemovska G Bosevska G Georgievska-Ismail L Clinical role of estimation metabolic syndrome’s components in type 2 diabetic population with symptomatic coronary artery disease – a comparison of two criteria Med Arh 2010 64 3 144 146 20645505
   PubMedGoogle Scholar
• del Cañizo-Gómez FJ Moreira-Andrés MN Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines? Diabetes Res Clin Pract 2004 65 2 125 133 15223224
   PubMed Web of Science ®Google Scholar
• Agha A Dillon D Corbett M Sreenan S Target blood pressure for patients with type 2 diabetes is difficult to achieve in the setting of a busy diabetes clinic Ir J Med Sci 2003 172 4 168 170 15029982
   PubMed Web of Science ®Google Scholar
• Babeş EB Babeş V Ofrim D Toadere A Prevalence and prognostic significance of silent myocardial ischemia in diabetic patients with and without hypertension Arch Balk Med Union 2009 44 3 210 214
   Google Scholar
• Suh DC Kim CM Choi IS Plauschinat CA Barone JA Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004 J Hypertens 2009 27 9 1908 1916 19491704
   PubMedGoogle Scholar
• Foucan L Deloumeaux J Donnet JP Metabolic syndrome components in Indian migrants with type 2 diabetes. A matched comparative study Diabetes Metab 2006 32 4 337 342 16977261
   PubMed Web of Science ®Google Scholar
• Jiménez-Corona A Rojas R Gómez-Pérez FJ Aguilar-Salinas CA Early-onset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006 Salud Publica Mex 2010 52 Suppl 1 S27 S35 20585726
   PubMed Web of Science ®Google Scholar
• Leitão CB Canani LH Kramer CK Blood pressure means rather than nocturnal dipping pattern are related to complications in Type 2 diabetic patients Diabet Med 2008 25 3 308 313 18201207
   PubMed Web of Science ®Google Scholar
• Moehlecke M Leitão CB Kramer CK Effect of metabolic syndrome and of its individual components on renal function of patients with type 2 diabetes mellitus Braz J Med Biol Res 2010 43 7 687 693 20549138
   PubMed Web of Science ®Google Scholar
• Wobeto VP Pinho Pda C Souza JR Zaccariotto TR Zonati Mde F Haptoglobin genotypes and refractory hypertension in type 2 diabetes mellitus patients Arq Bras Cardiol 2011 97 4 338 345 English and Portuguese 22011804
   PubMed Web of Science ®Google Scholar
• Ezenwaka CE Offiah NV Cardiovascular risk in obese and nonobese patients with type 2 diabetes in the West Indies J Biomed Sci 2001 8 4 314 320 11455193
   PubMed Web of Science ®Google Scholar
• Ezenwaka CE Nwagbara E Seales D A comparative study of the prevalence of the metabolic syndrome and its components in type 2 diabetic patients in two Caribbean islands using the new International Diabetes Federation definition Arch Physiol Biochem 2007 113 4–5 202 210 17852050
   PubMedGoogle Scholar
• Hermans MP Amoussou-Guenou KD Ahn SA Rousseau MF Impact of metabolic syndrome and its severity on microvascular complications in type 2 diabetes Diabetes Metab Syndr Clin Res Rev 2010 4 3 150 154
   Google Scholar
• Fasanmade OA Okubadejo NU Magnitude and gender distribution of obesity and abdominal adiposity in Nigerians with type 2 diabetes mellitus Niger J Clin Pract 2007 10 1 52 57 17668716
   PubMedGoogle Scholar
• Ogawa K Ueda K Sasaki H History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy Diabetes Res Clin Pract 2004 66 Suppl 1 S165 S168 15563970
   PubMed Web of Science ®Google Scholar
• Marjani A Prevalence of obesity among type 2 diabetes mellitus in Gorgan (South East of Caspian Sea), Iran J Chin Clin Med 2011 6 2 85 92
   Google Scholar
• Bianchi C Penno G Malloggi L Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome Nutr Metab Cardiovasc Dis 2008 18 1 31 38 17420118
   PubMed Web of Science ®Google Scholar
• Klein S Allison DB Heymsfield SB Association for Weight Management and Obesity Prevention NAASO, The Obesity Society American Society for Nutrition American Diabetes Association Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the ADA Am J Clin Nutr 2007 85 5 1197 1202 17490953
   PubMed Web of Science ®Google Scholar
• Bener A Zirie M Al-Rikabi A Genetics, obesity, and environmental risk factors associated with type 2 diabetes Croat Med J 2005 46 2 302 307 15849854
   PubMed Web of Science ®Google Scholar
• Mulnier HE Seaman HE Raleigh VS Soedamah-Muthu SS Colhoun HM Lawrenson RA Mortality in people with type 2 diabetes in the UK Diabet Med 2006 23 5 516 521 16681560
   PubMed Web of Science ®Google Scholar
• Daousi C Casson IF Gill GV MacFarlane IA Wilding JP Pinkney JH Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors Postgrad Med J 2006 82 966 280 284 16597817
   PubMed Web of Science ®Google Scholar
• Hillier TA Fosse S Balkau B Simon D Eschwège E Fagot-Campagna A Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study J Cardiometab Syndr 2006 1 5 318 325 17679788
   PubMedGoogle Scholar
• Ridderstråle M Gudbjörnsdottir S Eliasson B Nilsson PM Cederholm J Steering Committee of the Swedish National Diabetes Register (NDR) Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register J Intern Med 2006 259 3 314 322 16476109
   PubMed Web of Science ®Google Scholar
• Poljicanin T Pavlic′-Renar I Metelko Z Obesity in type 2 diabetes: prevalence, treatment trends and dilemmas Coll Antropol 2011 35 3 829 834 22053563
   PubMedGoogle Scholar
• Kramer H Cao G Dugas L Luke A Cooper R Durazo-Arvizu R Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys J Diabetes Complications 2010 24 6 368 374 19914095
   PubMed Web of Science ®Google Scholar
• Aguilar-Salinas CA Rojas R Gómez-Pérez FJ Prevalence and characteristics of early-onset type 2 diabetes in Mexico Am J Med 2002 113 7 569 574 12459403
   PubMed Web of Science ®Google Scholar
• Taruni N Romeo K Romola P Brojendro O David L Prevalence study of metabolic syndrome in newly detected diabetes patients in RIMS J Med Soc 2010 24 1 2 4
   Google Scholar
• Ezenwaka CE Offiah NV Abdominal obesity in type 2 diabetic patients visiting primary healthcare clinics in Trinidad, West Indies Scand J Prim Health Care 2002 20 3 177 182 12389757
   PubMed Web of Science ®Google Scholar
• Wilson C Gilliland S Moore K Acton K The epidemic of extreme obesity among American Indian and Alaska Native adults with diabetes Prev Chronic Dis 2007 4 1 A06 17173714
   PubMedGoogle Scholar
• Ravera M Noberasco G Re M Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective Nephrol Dial Transplant 2009 24 5 1528 1533 19073656
   PubMed Web of Science ®Google Scholar
• Hypertension in Diabetes Study (HDS): I Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications J Hypertens 1993 11 3 309 317 8387089
   PubMed Web of Science ®Google Scholar
• Reddy KS Regional case studies – India Nestle Nutr Workshop Ser Pediatr Program 2009 63 15 24 discussion 41–46, 259–268
   Google Scholar
• Barquera S Durazo-Arvizu RA Luke A Cao G Cooper RS Hypertension in Mexico and among Mexican Americans: prevalence and treatment patterns J Hum Hypertens 2008 22 9 617 626 18305546
   PubMed Web of Science ®Google Scholar
• Dorobantu M Darabont RO Badila E Ghiorghe S Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study Int J Hypertens 2010 2010 970694 20981313
   PubMedGoogle Scholar
• International Diabetes Federation (IDF) The IDF Worldwide Consensus Definition of the Metabolic Syndrome Brussels IDF 2006 Available from: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf Accessed February 14, 2013
   Google Scholar
• Misra A Chowbey P Makkar BM Consensus Group Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management J Assoc Physicians India 2009 57 163 170 19582986
   PubMedGoogle Scholar
• IDF The global burden [web page on the Internet] IDF Diabetes Atlas 5th ed Brussels IDF nd Available from: http://www.idf.org/diabetesatlas/5e/the-global-burden Accessed February 14, 2013
   Google Scholar
• WHO Global Health Observatory Data Repository Blood pressure: raised blood pressure (SBP ≥ 140 or DBP ≥ 90) [database on the Internet] Geneva WHO nd. Available from: http://apps.who.int/gho/data/?theme=main&node=A875# Accessed February 14, 2013
   Google Scholar
• WHO Global Health Observatory Data Repository Overweight/Obesity: obesity (body mass index ≥30) by country [database on the Internet] Geneva WHO nd. Available from: http://apps.who.int/gho/data/?theme=main&node=A900# Accessed February 14, 2013
   Google Scholar
• Cheng XB Hsieh YT Tu ST Hsieh MC Obesity and low target attainment rates in Chinese with type 2 diabetes Eur J Intern Med 2012 23 4 e101 e105 22560392
   PubMed Web of Science ®Google Scholar
• DiBonaventura MD Liu GG Stankus A The prevalence and burden of comorbid hypertension and obesity among patients with type 2 diabetes in Urban China Value Health 2012 15 7 A664
   Web of Science ®Google Scholar
• Feng RN Zhao C Wang C Niu YC Li K Guo FC BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults J Epidemiol 2012 22 4 317 323 22672914
   PubMed Web of Science ®Google Scholar
• Hossain MS Rahaman MZ Banik S Sarwar MS Yokota K Prevalence of the metabolic syndrome in diabetic patients living in a coastal region of Bangladesh Int J Pharm Sci Res 2012 3 8 2633 2638
   Google Scholar
• Katchunga P Masumbuko B Belma M Kashongwe Munogolo Z Hermans MP M’buyamba-Kabangu JR Age and living in an urban environment are major determinants of diabetes among South Congolese adults Diabetes Metab 2012 38 4 324 231 22483839
   PubMed Web of Science ®Google Scholar
• Frank LK Heraclides A Danquah I Bedu-Addo G Mockenhaupt FP Schulze MB Measures of general and central obesity and risk of type 2 diabetes in a Ghanaian population Trop Med Int Health 2013 18 2 141 151 23190041
   PubMed Web of Science ®Google Scholar
• Berraho M El Achhab Y Benslimane A El Rhazi K Chikri M Nejjari C Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study) Pan Afr Med J 2012 11 52 22593788
   PubMedGoogle Scholar
• Zhang P Zhang X Brown J Global healthcare expenditure on diabetes for 2010 and 2030 Diabetes Res Clin Pract 2010 87 3 293 301 20171754
   PubMed Web of Science ®Google Scholar
• Swinburn BA Sacks G Hall KD The global obesity pandemic: shaped by global drivers and local environments Lancet 2011 378 9793 804 814 21872749
   PubMed Web of Science ®Google Scholar
• Cecchini M Sassi F Lauer JA Lee YY Guajardo-Barron V Chisholm D Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness Lancet 2010 376 9754 1775 1784 21074255
   PubMed Web of Science ®Google Scholar
• Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Washington DC US Department of Health and Human Services 2004 Available from: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf Accessed February 10, 2013
   Google Scholar
• White J Efficacy and safety of incretin based therapies: clinical trial data J Am Pharm Assoc (2003) 2009 49 Suppl 1 S30 S40 19801363
   PubMed Web of Science ®Google Scholar